Table 1. Baseline summary statistics and details of studies included in the analyses of body mass index and site-specific cancer mortality in the Asia-Pacific Cohort Studies Collaboration (APCSC).
| Study name | Sample size | Years of baseline survey | Age at baseline (yr) | % female | BMI (kg/m2) | Median follow-up | Liver cancer deaths | All liver disease deaths | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | |||||||
| Akabane | 1833 | 85-86 | 54 | 8 | 55.7 | 22.5 | 3.0 | 11 | 2 | 2 |
| Anzhen | 8344 | 91 | 54 | 13 | 55.1 | 23.9 | 3.7 | 4 | 6 | 6 |
| CISCH | 2164 | 92-93 | 44 | 7 | 50.8 | 24.7 | 3.4 | 3 | 2 | 2 |
| Civil Serivce Workers | 9312 | 90-92 | 47 | 5 | 33.1 | 22.5 | 2.7 | 7 | 7 | 8 |
| CVDFACTS | 5704 | 88-96 | 47 | 15 | 55.3 | 23.5 | 3.4 | 6 | 0 | 5 |
| Fangshan | 2606 | 91-92 | 47 | 10 | 66.6 | 24.4 | 3.6 | 4 | 0 | 2 |
| Guangzhou Occupational | 20524 | 85-97 | 42 | 6 | 31.7 | 22.5 | 2.9 | 8 | 0 | 5 |
| Hisayama | 1516 | 61 | 56 | 11 | 56.1 | 21.6 | 2.6 | 25 | 14 | 25 |
| Hong Kong | 2767 | 85-91 | 78 | 7 | 56.8 | 22.1 | 3.7 | 3 | 10 | 11 |
| Huashan | 1852 | 90-92 | 53 | 12 | 52.0 | 23.4 | 3.4 | 3 | 0 | 2 |
| Kinmen | 1266 | 93-96 | 63 | 9 | 46.9 | 23.4 | 3.4 | 3 | 0 | 2 |
| KMIC | 183368 | 92 | 44 | 7 | 37.0 | 23.0 | 2.5 | 4 | 199 | 379 |
| Konan | 1192 | 87-95 | 52 | 16 | 55.3 | 21.9 | 3.0 | 6 | 3 | 5 |
| Miyama | 1031 | 88-90 | 60 | 9 | 55.3 | 22.1 | 2.9 | 7 | 0 | 4 |
| Saitama | 3599 | 86-90 | 54 | 12 | 62.1 | 22.4 | 2.9 | 11 | 11 | 12 |
| Seven Cities Cohorts | 10705 | 87 | 54 | 12 | 54.4 | 22.7 | 3.6 | 3 | 6 | 11 |
| Shibata | 2328 | 77 | 57 | 11 | 57.7 | 22.4 | 3.0 | 20 | 10 | 20 |
| Shigaraki Town | 3731 | 91-97 | 57 | 14 | 59.4 | 22.5 | 3.1 | 4 | 0 | 1 |
| Shirakawa | 4636 | 74-79 | 48 | 12 | 54.3 | 21.5 | 2.7 | 18 | 7 | 17 |
| Singapore Heart | 2304 | 82-97 | 41 | 13 | 49.0 | 23.6 | 4.3 | 15 | 1 | 5 |
| Singapore NHS92 | 3293 | 92 | 39 | 12 | 51.7 | 23.3 | 4.1 | 6 | 1 | 1 |
| Six Cohorts | 19329 | 82-86 | 45 | 7 | 46.7 | 21.2 | 2.6 | 9 | 111 | 146 |
| Tianjin | 9228 | 84 | 54 | 12 | 51.1 | 23.6 | 3.9 | 6 | 17 | 38 |
| Yunnan | 6571 | 92 | 56 | 9 | 3.1 | 21.6 | 2.9 | 4 | 13 | 25 |
| Total Asia | 309203 | 61-97 | 53 | 14 | 40.5 | 22.7 | 2.9 | 4 | 420 | 734 |
| Melbourne | 41240 | 90-94 | 55 | 9 | 58.9 | 26.9 | 4.4 | 8 | 11 | 18 |
| Busselton | 7439 | 66-81 | 45 | 17 | 52.0 | 24.6 | 3.8 | 27 | 5 | 18 |
| Fletcher Challenge | 10329 | 92-94 | 44 | 15 | 28.0 | 26.4 | 4.1 | 6 | 2 | 3 |
| Perth | 10222 | 78-94 | 45 | 13 | 48.2 | 25.2 | 3.9 | 14 | 3 | 8 |
| ANHF | 9256 | 89-90 | 43 | 13 | 50.9 | 25.4 | 4.2 | 8 | 0 | 2 |
| Newcastle | 5920 | 83-94 | 52 | 10 | 50.2 | 26.7 | 4.5 | 9 | 1 | 1 |
| Western AAAA Screenees | 12190 | 96-99 | 72 | 4 | 0.0 | 26.9 | 3.7 | 3 | 3 | 8 |
| Total ANZ | 96596 | 66-99 | 53 | 14 | 45.2 | 25.9 | 4.3 | 8.3 | 25 | 58 |
| Overall total | 405799 | 61-99 | 48 | 11 | 41.6 | 23.7 | 3.6 | 4 | 445 | 792 |
Abbreviations: ANZ, Australia and New Zealand; SD, standard deviation. Study abbreviations: WA AAA Screenees, Western Australian Abdominal Aortic Aneurysm Screening Program; CISCH, Capital Iron and Steel Company Hospital Cohort; CVDFACTS, Cardiovascular Disease Risk Factors Two-Township Study; KMIC, Korean Medical Insurance Company; Singapore NHS92, Singapore National Health Survey 1992; EGAT, Electricity Generating Authority of Thailand